Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
4.48M
-
Shares change
-
-85.5K
-
Total reported value, excl. options
-
$407M
-
Value change
-
-$6.24M
-
Put/Call ratio
-
0.31
-
Number of buys
-
70
-
Number of sells
-
-39
-
Price
-
$90.70
Significant Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q1 2024
148 filings reported holding PPH - VANECK ETF TRUST - PHARMACEUTCL ETF as of Q1 2024.
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.48M shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (1.35M shares), BANK OF AMERICA CORP /DE/ (409K shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (319K shares), Avalon Trust Co (285K shares), NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (157K shares), Miller Investment Management, LP (144K shares), Prime Capital Investment Advisors, LLC (140K shares), JPMORGAN CHASE & CO (107K shares), MORGAN STANLEY (105K shares), and LPL Financial LLC (93.3K shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.